drugset / Trial / NCT06631417
A Study in Healthy People to Test How 2 Different Doses of BI 1291583 Are Taken up in the Body When Given in 3 Different Formulations
RandomizedCrossoverOpen-labelTreatment
Summary
The main objective of this trial is to investigate the relative bioavailability of two different formulations of BI 1291583 (test formulations) compared to BI 1291583 reference formulation administered at two different dose levels.
Timeline
- Start
- 2024-10-22
- Primary completion
- 2025-01-10
- Completion
- 2025-05-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1291583 | Unknown | — | Oral |
Indications
No indication recorded.